Cibc Asset Management Inc Bio Rad Laboratories, Inc. Transaction History

Cibc Asset Management Inc

$31.2 Billion
Q3 2025

A detailed history of Cibc Asset Management Inc transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Cibc Asset Management Inc holds 725 shares of BIO stock, worth $225,786. This represents 0.0% of its overall portfolio holdings.

Number of Shares

725

Holding current value

$225,786

% of portfolio

0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 31, 2025	BUY	$241.95 - $303.82 $175,413 - $220,269	725 New	725 $203,000
Q4 2024 Jan 31, 2025	BUY	$313.15 - $374.28 $10,647 - $12,725	34 Added 5.01%	713 $234,000
Q3 2024 Nov 06, 2024	SELL	$263.97 - $344.64 $537,706 - $702,031	-2,037 Reduced 75.0%	679 $227,000
Q2 2024 Aug 01, 2024	SELL	$268.26 - $339.48 $61,968 - $78,419	-231 Reduced 7.84%	2,716 $741,000
Q1 2024 May 09, 2024	BUY	$304.11 - $351.99 $23,416 - $27,103	77 Added 2.68%	2,947 $1.02 Million
Q4 2023 Feb 13, 2024	SELL	$269.37 - $365.04 $26,667 - $36,138	-99 Reduced 3.33%	2,870 $926,000
Q3 2023 Oct 30, 2023	SELL	$350.25 - $422.63 $21,015 - $25,357	-60 Reduced 1.98%	2,969 $1.06 Million
Q2 2023 Aug 14, 2023	SELL	$359.49 - $486.4 $12,222 - $16,537	-34 Reduced 1.11%	3,029 $1.15 Million
Q1 2023 May 12, 2023	SELL	$418.69 - $503.0 $22,190 - $26,659	-53 Reduced 1.7%	3,063 $1.47 Million
Q4 2022 Feb 13, 2023	SELL	$351.71 - $456.01 $4,572 - $5,928	-13 Reduced 0.42%	3,116 $1.31 Million
Q3 2022 Nov 03, 2022	BUY	$412.59 - $563.26 $70,965 - $96,880	172 Added 5.82%	3,129 $1.31 Million
Q2 2022 Aug 09, 2022	SELL	$463.67 - $597.16 $1.05 Million - $1.35 Million	-2,263 Reduced 43.35%	2,957 $1.46 Million
Q1 2022 May 06, 2022	SELL	$524.57 - $735.42 $578,600 - $811,168	-1,103 Reduced 17.44%	5,220 $2.94 Million
Q4 2021 Feb 08, 2022	BUY	$708.84 - $794.68 $57,416 - $64,369	81 Added 1.3%	6,323 $4.78 Million
Q3 2021 Nov 09, 2021	BUY	$657.71 - $825.77 $164,427 - $206,442	250 Added 4.17%	6,242 $4.66 Million
Q2 2021 Aug 16, 2021	BUY	$576.64 - $649.04 $302,159 - $340,096	524 Added 9.58%	5,992 $3.86 Million
Q1 2021 May 14, 2021	BUY	$547.01 - $662.35 $183,795 - $222,549	336 Added 6.55%	5,468 $3.12 Million
Q4 2020 Feb 03, 2021	BUY	$510.68 - $643.45 $112,860 - $142,202	221 Added 4.5%	5,132 $2.99 Million
Q3 2020 Nov 05, 2020	BUY	$454.43 - $535.6 $1.26 Million - $1.49 Million	2,780 Added 130.46%	4,911 $2.53 Million
Q2 2020 Jul 28, 2020	BUY	$334.87 - $493.06 $347,929 - $512,289	1,039 Added 95.15%	2,131 $962,000
Q4 2019 Feb 14, 2020	BUY	$319.73 - $374.2 $3,517 - $4,116	11 Added 1.02%	1,092 $404,000
Q2 2018 Aug 09, 2018	BUY	$244.1 - $303.88 $8,543 - $10,635	35 Added 3.35%	1,081 $312,000
Q3 2017 Nov 06, 2017	BUY	$212.27 - $242.28 $222,034 - $253,424	1,046	1,046 $232,000

Others Institutions Holding BIO

# of Institutions

438

Shares Held

19.2M

Call Options Held

10.7K

Put Options Held

35.5K

View Full List

About BIO-RAD LABORATORIES, INC.

Ticker BIO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,633,900
Market Cap $7.67B
Description
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...

More about BIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Cibc Asset Management Inc with notifications on news.

Account

Cibc Asset Management Inc Bio Rad Laboratories, Inc. Transaction History